What is the consensus on giving Pemivibart for Pre-Exposure COVID prophylaxis in immunocompromised patients?
1 Answers
Mednet Member
Medical Oncology · UPMC Hillman Cancer Center
The SARS-COV2 virus that caused COVID-19 infection in the early pandemic caused significant morbidity and mortality to immunocompromised patients including those with blood cancers. Therapies such as remdesivir, paxlovid, antibody neutralizing therapeutics Evusheld antibody for prophylaxis, and the ...